Kitasato University in Discussions with Merck to Conduct Ivermectin Clinical Trial Targeting COVID-19

Kitasato University in Discussions with Merck to Conduct Ivermectin Clinical Trial Targeting COVID-19

The word on Ivermectin as a potential approach to therapeutically countering COVID-19 is now getting out there—this time with Nikkei Asian Review. TrialSite News has followed the progression of the off-label approach of this anti-parasite drug carefully. Most recently, University of Kentucky announced that the common, cheap drug would be used in a clinical trial. Now a Japanese media offers updates including the fact that Kitasato University is in discussions with Merck's Japanese subsidiary to consider a clinical trial there.

The Japanese Connection

A Kitasato University Professor named Satoshi Omura, a 2015 Nobel Prize winner, developed the original findings that was thereafter used to create the drug. Now Nikkei Asian Review reports that the Tokyo-based university (Kitasato University) will consider a clinical trial using the drug to target COVID-19.

The Australian Spark

It was, of course, a group of researchers in Australia that was the catalyst for this emerging global interest in Ivermectin. A team from Monash University’s Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity at Royal Melbourne Hospital published a study...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee